Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo
ShareXFacebook

(MedPage Today) -- The phase III OPTIMA trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, showed that some patients with high-risk, early-stage, estrogen receptor (ER)-positive, HER2-negative breast cancer...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Watching the NBA Finals? Think Twice Before Betting
MedPage Today

Watching the NBA Finals? Think Twice Before Betting

(MedPage Today) -- I am a child of the golden era of basketball. I grew up watching Larry Legend (Larry Bird) and Earvin "Magic" Johnson duel through the 1980s. I was in ecstasy when my beloved Detroit Bad Boys dethroned both Goliaths, and for...

Read more →
Advertisement